Next Article in Journal
Epigenetic Control of Cytomegalovirus Latency and Reactivation
Previous Article in Journal
The Dynamics of HCF-1 Modulation of Herpes Simplex Virus Chromatin during Initiation of Infection
Review

Hepatitis C Virus, Cholesterol and Lipoproteins — Impact for the Viral Life Cycle and Pathogenesis of Liver Disease

1
Inserm, U1110, Institute of Virology, Strasbourg 67000, France
2
Université de Strasbourg, Strasbourg 67000, France
3
Universitaires de Strasbourg, Strasbourg 67000, France
*
Author to whom correspondence should be addressed.
Viruses 2013, 5(5), 1292-1324; https://doi.org/10.3390/v5051292
Received: 18 March 2013 / Revised: 10 April 2013 / Accepted: 27 April 2013 / Published: 23 May 2013
(This article belongs to the Section Animal Viruses)
Hepatitis C virus (HCV) is a leading cause of chronic liver disease, including chronic hepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma. Hepatitis C infection associates with lipid and lipoprotein metabolism disorders such as hepatic steatosis, hypobetalipoproteinemia, and hypocholesterolemia. Furthermore, virus production is dependent on hepatic very-low-density lipoprotein (VLDL) assembly, and circulating virions are physically associated with lipoproteins in complexes termed lipoviral particles. Evidence has indicated several functional roles for the formation of these complexes, including co-opting of lipoprotein receptors for attachment and entry, concealing epitopes to facilitate immune escape, and hijacking host factors for HCV maturation and secretion. Here, we review the evidence surrounding pathogenesis of the hepatitis C infection regarding lipoprotein engagement, cholesterol and triglyceride regulation, and the molecular mechanisms underlying these effects. View Full-Text
Keywords: Hepatitis C virus; lipoproteins; apolipoproteins; apoE; apoB; cholesterol; triglyceride; viral attachment; entry; assembly; secretion; viral immune escape; lipid disorder Hepatitis C virus; lipoproteins; apolipoproteins; apoE; apoB; cholesterol; triglyceride; viral attachment; entry; assembly; secretion; viral immune escape; lipid disorder
Show Figures

Figure 1

MDPI and ACS Style

Felmlee, D.J.; Hafirassou, M.L.; Lefevre, M.; Baumert, T.F.; Schuster, C. Hepatitis C Virus, Cholesterol and Lipoproteins — Impact for the Viral Life Cycle and Pathogenesis of Liver Disease. Viruses 2013, 5, 1292-1324. https://doi.org/10.3390/v5051292

AMA Style

Felmlee DJ, Hafirassou ML, Lefevre M, Baumert TF, Schuster C. Hepatitis C Virus, Cholesterol and Lipoproteins — Impact for the Viral Life Cycle and Pathogenesis of Liver Disease. Viruses. 2013; 5(5):1292-1324. https://doi.org/10.3390/v5051292

Chicago/Turabian Style

Felmlee, Daniel J., Mohamed L. Hafirassou, Mathieu Lefevre, Thomas F. Baumert, and Catherine Schuster. 2013. "Hepatitis C Virus, Cholesterol and Lipoproteins — Impact for the Viral Life Cycle and Pathogenesis of Liver Disease" Viruses 5, no. 5: 1292-1324. https://doi.org/10.3390/v5051292

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop